Our Company
Together with prescribers and pharmacists, Fagron strives to improve personalized medicine and to make it (more) accessible for patients. In this way, we aim to have a significant impact on the health and welfare of people.
Share
Fagron shares are listed on Euronext Brussels and Euronext Amsterdam. In this section, you can find more information about inter alia share performance, major shareholders, management shareholdings, shareholder notifications and dividend.
Press and Publications
In this section you can search in our archive of press releases, financial results, annual reports, presentations, and other publications. You can search by year or by document type.
ESG Management and Strategy
ESG lies at the core of Fagron’s activities and strategy.
Governance
As a global company with the ambition to create the future of personalized medicine, Fagron is committed to ensuring good corporate governance. In this section you can find Fagron's governance documents, policies and details about Fagron's management structure.
Calendar
Please find below the Investor Relations schedule for the coming period.

Press releases

All press releases published by Fagron are available on this page.

Investors Press releases

Filter by year

Language

CEO Ger van Jeveren verlaat Fagron

Fagron NV: Openbaarmaking van ontvangen kennisgevingen

Fagron reageert op berichten in de pers van maandag 30 november 2015

Fagron NV: Openbaarmaking van ontvangen kennisgevingen

Fagron realiseert omzetgroei van 3,5% over 3e kwartaal 2015

Fagron ontvangt indications of interest en informeert de markt over de vooruitzichten voor het jaar 2015

Fagron NV: Publicatie van garantenlijst en verklaring van nakoming

Fagron NV: Openbaarmaking van ontvangen kennisgeving

Fagron NV: Openbaarmaking van ontvangen kennisgeving

Fagron NV: Openbaarmaking van ontvangen kennisgeving